Skip to main content

Pharmacy

By Jeff Lagasse | 11:48 am | October 11, 2022
Only about one-third of adults have received the booster aimed at the Omicron variant, which remains highly transmissible.
By Jeff Lagasse | 12:09 pm | October 03, 2022
High drug prices create affordability challenges for patients and the healthcare system, one of two reports found.
By Jeff Lagasse | 03:42 pm | September 27, 2022
NACDS also wants to establish a Medicare reimbursement pathway for pharmacy care services including vaccinations and therapeutics.
By Jeff Lagasse | 03:05 pm | September 21, 2022
The pitch to potential users is an integrated solution from one company that offers a more holistic approach to care.
HIMSS22
By HIMSS TV | 06:00 am | September 09, 2022
<p>Bob Katter, president of First Databank, explains how the FDB Vela electronic prescribing network can improve contracting and access for clinicians and pharmacies.</p>
By Susan Morse | 07:15 pm | August 31, 2022
The BA.4 and BA.5 lineages of the omicron variant are currently causing most cases of COVID-19 and are predicted to circulate this fall.
By Jeff Lagasse | 03:15 pm | August 24, 2022
BCBS is accusing Teva of offering coupons to prevent consumers from switching to a generic, lower-cost version of Copaxone.
By Susan Morse | 11:35 am | August 18, 2022
Health officials are trying to move all vaccines to intradermal dosing as in a strategy to stretch supply.
By Jeff Lagasse | 03:33 pm | August 15, 2022
Part D's programmatic structure may lead to plan sponsors preferring higher-cost versions of hepatitis C drugs, OIG finds.
By Jeff Lagasse | 10:41 am | December 23, 2021
The treatment has been cleared for anyone 12 years old and older who is at high risk for severe COVID-19, including hospitalization and death.